A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, 60-Week, Phase II Clinical Trial of Three Re-Purposed Medications in Moderate Severity Parkinson’s Disease

  • Rowe, Dominic (Primary Chief Investigator)
  • Gan, Richard, (Research Coordinator)

Project: Research

Project Details

Short titleAPM001
StatusActive
Effective start/end date10/09/2029/07/25